Cited by 752T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; none of the 115 sources its claims cite is checked for support yet.

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Open access
Crespo, Joel, Sun, Haoyu, Welling, Theodore H, Tian, Zhigang, Zou, Weiping·2013·Current Opinion in Immunology

Abstract

Human tumors progress despite the presence of tumor associated antigen (TAA)-specific T cells. Many different molecular and cellular mechanisms contribute to the failure of T cells to eradicate the tumor. These include immune suppressive networks that impair ongoing T cell function and enable tumor escape. Recent studies have started to reveal the nature of effector T cells in the tumor microenvironment. In this article we discuss T cell anergy, exhaustion, senescence, and stemness, and review the phenotype of dysfunctional T cell subsets and the underlying molecular mechanisms in the tumor microenvironments. We suggest that targeting T cell dysfunctional mechanisms and introducing/promoting T cell stemness are important approaches to treat patients with cancer.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.coi.2012.12.003

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 115 cited sources checked · 0 supported · 0 flagged

Show all 38 claims

  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 4
32 of 32
  • The paper relies on this without support.

    Human tumors progress despite the presence of tumor-associated antigen-specific T cells.

    “Human tumors progress despite the presence of tumor associated antigen (TAA)-specific T cells.”
  • The paper relies on this without support.

    T cell exhaustion occurs when T cells are chronically activated at sites of chronic inflammation, such as cancer, autoimmunity, and chronic infection.

    “T cell exhaustion occurs when T cells are chronically activated at sites of chronic inflammation, such as cancer, autoimmunity, and chronic infection.”
  • The authors state this as an assumption.

    The tumor microenvironment provides the necessary conditions for effector T cells to become functionally exhausted and to maintain this state during disease progression.

    “Nonetheless, it is assumed that the tumor microenvironment provides the necessary conditions for effector T cells to become functionally exhausted as well as being able to maintain this state during disease progression.”
  • The paper relies on this without support.

    These markers are not mutually exclusive or inclusive in a given T cell subset.

    “However, these markers are not mutually exclusive and inclusive in a given T cell subset.”
  • The paper relies on this without support.

    PD-1+ cells may express Tim-3 and LAG-3.

    “PD-1+ cells may express Tim-3 and LAG-3.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 77 references

Cited by

Sorted by citations

Items 101–200 of 750

Metadata

Authors
Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W.
Affiliations
  • University of Michigan (US)
  • University of Science and Technology of China (CN)
Corresponding author
  • Tian, Zhigang
  • Zou, Weiping
Venue
Current Opinion in Immunology
Publisher
Elsevier BV
Published
2013-04
Volume
25
Issue
2
Pages
214-221
ISSN
0952-7915 (ISSN-L)
OpenAlex
W2050558251
Cited by
752
References
77
Citations by year
2026: 32 · 2025: 67 · 2024: 74 · 2023: 76 · 2022: 73 · 2021: 80 · 2020: 63 · 2019: 59 · 2018: 61 · 2017: 52 · 2016: 42 · 2015: 42 · 2014: 23 · 2013: 8
FWCI
3.34
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5t32ai007413-32)
  • National Cancer Institute (R01CA123088, R01CA152470, R01CA156685, K08CA151414, R01CA099985)
  • National Institute of Allergy and Infectious Diseases (T32-AI-007413)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
T cell anergy, T cell exhaustion, T cell senescence, T cell stemness, tumor microenvironment, tumor-associated antigens, immune evasion, immunosuppression, cancer immunotherapy
MeSH terms
Animals, Humans, Neoplasms, Stem Cells, T-Lymphocytes, Cellular Senescence, Clonal Anergy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review